SCHEMBL29913258

SCHEMBL29913258

COc1cccc(C=CC(=O)N2CCNCC2)c1OC

nearest known ligand 0.64

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 2/20 0.64
KMT2A Q03164 1/20 0.64
LMNA P02545 1/20 0.61
HPGD P15428 3/20 0.61
KDM4E B2RXH2 2/20 0.57
L3MBTL1 Q9Y468 1/20 0.56
CYP1A1 P04798 1/20 0.54
CYP1A2 P05177 1/20 0.54
CYP2D6 P10635 1/20 0.54
LY96 Q9Y6Y9 1/20 0.54
ALDH1A1 P00352 1/20 0.51
ALOX5 P09917 1/20 0.51
TRPM8 Q7Z2W7 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11472480 0.89 ABCG2 (0.56) NFE2L2KMT2ALMNAHPGDKDM4E
SCHEMBL11472479 0.89 ABCG2 (0.56) NFE2L2KMT2ALMNAHPGDKDM4E
SCHEMBL27980821 0.84 HPGD (0.54) NFE2L2KMT2ALMNAHPGDKDM4E
SCHEMBL14218138 0.83 LMNA (0.62) NFE2L2KMT2ALMNAHPGDKDM4E
SCHEMBL14190940 0.80 KMT2A (0.61) NFE2L2KMT2ALMNAHPGDKDM4E
SCHEMBL4382984 0.80 KMT2A (0.61) NFE2L2KMT2ALMNAHPGDKDM4E
SCHEMBL4378985 0.80 LMNA (0.59) NFE2L2KMT2ALMNAHPGDKDM4E
SCHEMBL14190946 0.80 LMNA (0.59) NFE2L2KMT2ALMNAHPGDKDM4E
SCHEMBL2831501 0.80 HPGD (0.61) NFE2L2KMT2ALMNAHPGDKDM4E
SCHEMBL2744353 0.79 NFE2L2 (1.00) NFE2L2KMT2ALMNAKDM4ECYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110498761-B Application of acetyl amantadine piperazine (pyridine) compound as cerebral nerve protective agent 上海医药工业研究院 2022-09-13 CN claimed
CN-110498761-B Application of acetyl amantadine piperazine (pyridine) compound as cerebral nerve protective agent 上海医药工业研究院 2022-09-13 CN disclosed